Full Breakdown
Mass General Brigham Health Plan Ends Dana-Farber Coverage in Medicare Advantage Network
9/6/2026, 12:35:27 AM
Core Change and Immediate Impact
The Mass General Brigham (MGB) Health Plan is removing the Dana-Farber Cancer Institute from its Medicare Advantage provider network. The shift will affect roughly 1,000 enrollees who currently receive cancer care at Dana-Farber, including long-time patients such as 88-year-old Eldon Clingan, who has been treated there for more than two decades. Patients have a 90-day transition window to secure alternative coverage; after the start of the new year, continued treatment at Dana-Farber would require a different insurance plan.
Background and Context
The network change follows Dana-Farber’s decision to end its long-term partnership with the MGB hospital system, a separation slated for 2028.
Official Statements & Responses
The insurer emphasized that the decision is not linked to the clinical realignment between the two Boston-area cancer providers. No alternative coverage options specific to Dana-Farber were offered within the plan’s current formulary.
Verbatim Quotes
- “It adds to the anxiety and worry, which you know, at age 88 with cancer, you really do not need that kind of stress in your life,” — Eldon Clingan
- “Are they going to cover my medication, for example? This is very expensive medication,” — Eldon Clingan
- “I have had excellent care from my Dana-Farber doctor for 23 years and I want to stay with her,” — Eldon Clingan
- “I feel like I am collateral damage in this war,” — Eldon Clingan
Why It Matters
The network alteration forces senior cancer patients to confront potential disruptions in continuity of care, medication access, and physician relationships. For individuals like Clingan, the uncertainty adds emotional stress and raises financial questions about expensive oncology drugs. The episode highlights how insurer network decisions, driven by market pressures, can directly affect vulnerable patients’ treatment pathways.
